ProQR Therapeutics

PRQR

Market cap $252M

47 hedge funds and large institutions have $37.2M invested in ProQR Therapeutics in 2023 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 12 reducing their positions, and 5 closing their positions.

2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3 2019 Q2 2019 Q1 2018 Q4 2018 Q3 2018 Q2 2018 Q1 2017 Q4 2017 Q3 2017 Q2 2017 Q1 2016 Q4 2016 Q3 2016 Q2 2016 Q1 2015 Q4 2015 Q3 2015 Q2 2015 Q1 2014 Q4 2014 Q3

Holders

Holders Change

Holders Change %

+2.17%

% of All Funds

0.69%

Holding in Top 10

Holding in Top 10 Change

Holding in Top 10 Change %

+100%

% of All Funds

0.03%

New

Increased

Reduced

Closed

Calls

$156K

Puts

$44K

Net Calls

+$112K

Net Calls Change

+$168K

Top Buyers

1	1 Deutsche Bank Frankfurt Am Main Ge, Germany	$763K
2	2 Citadel Advisors Miami, Florida	$154K
3	VF 3 Virtu Financial New York	$69K
4	4 Bank of Montreal Toronto, Ontario, Canada	$66.3K
5	5 Millennium Management New York	$889K

Top Sellers

1	1 JPMorgan Chase & Co New York	$3.59K
2	UOC 2 UBS O'Connor Chicago, Illinois	$0
3	3 Morgan Stanley New York	$450K
4	4 Two Sigma Investments New York	$197K
5	5 Two Sigma Advisers New York	$334K